Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism
| Autor: | Chase W. Kessinger, Ahmed Tawakol, Farouc A. Jaffer, Eric A. Osborn |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Fluorescence-lifetime imaging microscopy
030204 cardiovascular system & hematology Bioinformatics Sensitivity and Specificity 030218 nuclear medicine & medical imaging Focus on Molecular Imaging 03 medical and health sciences 0302 clinical medicine Medicine Humans Radiology Nuclear Medicine and imaging Disease treatment medicine.diagnostic_test business.industry Vascular disease Reproducibility of Results Pet imaging Venous Thromboembolism medicine.disease Atherosclerosis Molecular Imaging Coronary arteries medicine.anatomical_structure Positron emission tomography Positron-Emission Tomography Molecular imaging Radiopharmaceuticals business Venous thromboembolism Biomarkers |
| Popis: | Metabolic and molecular imaging continues to advance our understanding of vascular disease pathophysiology. At present, 18F-FDG PET imaging is the most widely used clinical tool for metabolic and molecular imaging of atherosclerosis. However, novel nuclear tracers and intravascular optical near-infrared fluorescence imaging catheters are emerging to assess new biologic targets in vivo and in coronary arteries. This review highlights current metabolic and molecular imaging clinical and near-clinical applications within atherosclerosis and venous thromboembolism, and explores the potential for metabolic and molecular imaging to affect patient-level risk prediction and disease treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|